Fludarabine
Extramedullary Plasmacytoma
Institute of Hematology & Blood Diseases Hospital, ChinaSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
11 Active assets in the Extramedullary Plasmacytoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Stichting European Myeloma Network | Phase 3 | BB |
DEXAMETHASONE Stichting European Myeloma Network | Phase 3 | BB |
Cyclophosphamide Stichting European Myeloma Network | Phase 3 | BB |
Bortezomib Stichting European Myeloma Network | Phase 3 | BB |
ETOPOSIDE Margarida Magalhaes-Silverman | Phase 2 | B |
View all 24 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →